Get the Stockscreener App
2.13
22.41%
0.39
Matinas Biopharma Holdings Inc stock is traded at $2.13, with a volume of 357.41K.
It is up +22.41% in the last 24 hours and up +124.16% over the past month.
Matinas BioPharma Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of various product candidates. The company enables the delivery of life-changing medicines using its lipid nano-crystal (LNC) platform technology. Its LNC delivery technology platform utilizes lipid nano-crystals which can encapsulate small molecules, oligonucleotides, vaccines, peptides, proteins and other medicines potentially making them safer, more tolerable, less toxic, and orally bioavailable. The company's lead anti-fungal product candidate is MAT2203, an orally-administered cochleate formulation of amphotericin B that has completed Phase II clinical trials for the prevention of invasive fungal infections due to immunosuppressive therapy in patients with acute lymphoblastic leukemia. Its product candidates also comprise MAT2501, an orally administered cochleate formulation of the broad spectrum aminoglycoside antibiotic amikacin that has completed Phase I clinical trials to treat various types of multidrug-resistant bacteria, including non-tuberculous mycobacterium infections, as well as various multidrug-resistant gram negative and intracellular bacterial infections. The company was founded in 2013 and is based in Bedminster, New Jersey.
See More
Previous Close:
$1.74
Open:
$1.75
24h Volume:
357.41K
Relative Volume:
0.57
Market Cap:
$10.84M
Revenue:
-
Net Income/Loss:
$-21.13M
P/E Ratio:
-0.4447
EPS:
-4.79
Net Cash Flow:
$-16.95M
1W Performance:
-9.75%
1M Performance:
+124.16%
6M Performance:
+232.81%
1Y Performance:
+1,956%
1-Day Range:
$1.75
$2.1837
1-Week Range:
$1.33
$2.1837
52-Week Range:
$0.093
$4.49
Matinas Biopharma Holdings Inc Stock (MTNB) Company Profile
Name
Matinas Biopharma Holdings Inc
Sector
Industry
Phone
908-443-1860
Address
1545 Route 206 South, Suite 302, Bedminster, NJ
Compare MTNB with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MTNB
Matinas Biopharma Holdings Inc
|
2.13 | 8.70M | 0 | -21.13M | -16.95M | -4.79 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.12 | 99.96B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
589.48 | 60.83B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
454.38 | 59.89B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
660.00 | 40.47B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
313.67 | 37.96B | 3.81B | -644.79M | -669.77M | -6.24 |
Matinas Biopharma Holdings Inc Stock (MTNB) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| May-11-21 | Downgrade | Piper Sandler | Overweight → Neutral |
| Aug-26-20 | Resumed | Piper Sandler | Overweight |
| Jan-27-20 | Initiated | Piper Sandler | Overweight |
| Jan-24-20 | Initiated | SunTrust | Buy |
| Jan-23-20 | Initiated | SunTrust | Buy |
| Jan-09-20 | Initiated | Aegis Capital | Buy |
| Jun-26-19 | Initiated | H.C. Wainwright | Buy |
View All
Matinas Biopharma Holdings Inc Stock (MTNB) Latest News
Veren Inc. stock chart pattern explainedTrade Entry Summary & Precise Buy Zone Identification - Newser
Is this a good reentry point in Matinas BioPharma Holdings Inc.July 2025 Summary & Accurate Technical Buy Alerts - Newser
What candlestick patterns are forming on Matinas BioPharma Holdings Inc.Recession Risk & Risk Controlled Stock Alerts - Newser
What indicators show strength in Matinas BioPharma Holdings Inc.Weekly Risk Report & Capital Efficiency Focused Strategies - Newser
Matinas Biopharma Holdings, Inc. (NYSE:MTNB) Short Interest Down 42.2% in July - Defense World
What’s the recovery path for long term holders of Matinas BioPharma Holdings Inc.Earnings Growth Report & Community Verified Swing Trade Signals - Newser
Is Matinas BioPharma Holdings Inc. reversing from oversold territoryTrade Signal Summary & Expert Approved Momentum Ideas - Newser
What momentum shifts mean for EPAMRate Cut & Risk Adjusted Buy/Sell Alerts - Newser
Applying chart zones and confluence areas to Southland Holdings Inc.Weekly Trend Summary & Community Driven Trade Alerts - Newser
Real time pattern detection on Decent Holding Inc. stockExit Point & AI Enhanced Trading Alerts - Newser
Is PROS Holdings Inc. a candidate for recovery play2025 Major Catalysts & Pattern Based Trade Signal System - Newser
Building trade automation scripts for Matinas BioPharma Holdings Inc.Market Activity Report & Weekly Breakout Stock Alerts - Newser
Should you wait for a breakout in Sally Beauty Holdings Inc.Insider Buying & Low Risk Entry Point Guides - Newser
Using Ichimoku Cloud for Matinas BioPharma Holdings Inc. technicalsMarket Trend Report & Capital Protection Trade Alerts - Newser
Reversal indicators forming on Matinas BioPharma Holdings Inc. stock2025 Market Outlook & Risk Managed Investment Signals - Newser
Matinas BioPharma Holdings Inc. Stock Performance After Earnings: Historical Insights2025 Price Momentum & Short-Term Trading Alerts - Newser
Exit strategy if you’re trapped in Matinas BioPharma Holdings Inc.July 2025 Highlights & Growth Oriented Trade Recommendations - Newser
Matinas BioPharma exchanges warrants for 466,666 shares of common stock By Investing.com - Investing.com South Africa
How to forecast PAHC trends using time seriesQuarterly Growth Report & Fast Gain Swing Alerts - Newser
Will breakout in Matinas BioPharma Holdings Inc. lead to full recovery2025 Historical Comparison & Growth Oriented Trade Recommendations - Newser
Published on: 2025-08-19 04:22:26 - Newser
Can technical indicators confirm BILL Holdings Inc.’s reversalWeekly Gains Summary & Community Verified Swing Trade Signals - Newser
What earnings revisions data tells us about Tevogen Bio Holdings Inc.Quarterly Performance Summary & Weekly Watchlist for Consistent Profits - Newser
Penny Stocks on the Move: Today’s Top Gainers and Biggest Decliners - AInvest
Is Matinas BioPharma Holdings Inc. in a consolidation phase2025 EndofYear Setup & AI Based Buy and Sell Signals - newsimpact.co.kr
Matinas Biopharma Plummets 22.9%: Warrant Exchanges and Earnings Miss Trigger Turbulence - AInvest
US Stocks Mixed; Riskified Shares Dip After Q2 Results - Benzinga
Can momentum traders help lift The Ensign Group Inc.Sell Signal & Daily Oversold Stock Bounce Ideas - Newser
Quant Models Detect Momentum Reversal in Matinas BioPharma Holdings Inc.Sell Signal & Intraday High Probability Setup Alerts - Newser
Matinas Biopharma Plunges 14.83% After Warrant Exchange - AInvest
Matinas BioPharma exchanges warrants for 466,666 shares of common stock - Investing.com
Comparing ACHC in custom built stock radarsJuly 2025 Drop Watch & Accurate Buy Signal Alerts - Newser
Published on: 2025-08-18 06:06:05 - Newser
Matinas BioPharma Cancels Warrants in Stock Exchange - TipRanks
Will Universal Insurance Holdings Inc. continue its uptrendTrade Performance Summary & Low Drawdown Investment Ideas - Newser
Matinas BioPharma Holdings Inc. recovery potential after sell off2025 Fundamental Recap & Daily Technical Forecast Reports - Newser
Trend analysis for Wrap Technologies Inc. this week2025 Market Overview & AI Forecast for Swing Trade Picks - Newser
Has Matinas BioPharma Holdings Inc. found a price floorEarnings Growth Summary & Verified Stock Trade Ideas - Newser
Is DIH Holding US Inc. building a consolidation baseTrade Risk Assessment & Growth Oriented Trading Recommendations - Newser
Matinas BioPharma Holdings Inc. Stock Support and Resistance Levels You Should KnowJuly 2025 Trade Ideas & Long-Term Growth Portfolio Plans - Newser
Matinas BioPharma Holdings Inc. Stocks Attracting Dip BuyersShare Buyback & Reliable Entry Point Trade Alerts - 선데이타임즈
Will Aether Holdings Inc. stock split in the near futureRate Cut & Weekly Market Pulse Updates - Newser
Is a relief rally coming for VersaBank holders2025 Top Decliners & Technical Entry and Exit Alerts - Newser
Can technical indicators confirm Matinas BioPharma Holdings Inc.’s reversalIndex Update & Proven Capital Preservation Methods - Newser
Nvni Group Limited stock outlook for YEARWeekly Profit Report & High Accuracy Swing Entry Alerts - Newser
How Provident Financial Holdings Inc. stock performs during market volatilityChart Signals & Daily Entry Point Alerts - Newser
Matinas BioPharma Holdings Inc. Recovery Gathers Momentum on Chart SignalsEarnings Overview Summary & Weekly Top Performers Watchlists - 선데이타임즈
ZenaTech Inc. Stock Chart Analysis: Bullish or Bearish Pattern FormingBond Market & Capital Protection Trading Alerts - Newser
Key resistance and support levels for Matinas BioPharma Holdings Inc.July 2025 Selloffs & Smart Swing Trading Techniques - Newser
Matinas Biopharma (MTNB) Soars 59.39% on Explosive Intraday Surge—What’s Fueling the Momentum? - AInvest
How to track smart money flows in Cocrystal Pharma Inc.2025 Sector Review & Community Shared Stock Ideas - Newser
Matinas Biopharma Holdings Inc Stock (MTNB) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.94%
1.72%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):